Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart Failure ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Exercise pathophysiology in patients with primary pulmonary hypertension.Circulation. 2001; 104: 429-435
- ATS/ACCP statement on cardiopulmonary exercise testing.Am J Respir Crit Care Med. 2003; 167: 211-277
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension.Eur Respir J. 2019; 53: 1801913
- Pulmonary arterial hypertension.N Engl J Med. 2021; 385: 2361-2376
- Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension.Chest. 1987; 92: 57-62
- Pulmonary vascular disease and cardiopulmonary exercise testing.Front Physiol. 2020; 11: 964
- Cardiopulmonary exercise testing in pulmonary hypertension.Ann ATS. 2017; 14: S84-S92
- A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.N Engl J Med. 1996; 334: 296-301
- Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.J Am Coll Cardiol. 2010; 55: 1915-1922
- Sildenafil citrate therapy for pulmonary arterial hypertension.N Engl J Med. 2005; 353: 2148-2157
- Tadalafil therapy for pulmonary arterial hypertension.Circulation. 2009; 119: 2894-2903
- Clinical trial design and new therapies for pulmonary arterial hypertension.Eur Respir J. 2019; 53https://doi.org/10.1183/13993003.01908-2018
- The role of cardiopulmonary exercise tests in pulmonary arterial hypertension.Eur Respir Rev. 2018; 27https://doi.org/10.1183/16000617.0134-2017
- Risk stratification and medical therapy of pulmonary arterial hypertension.Eur Respir J. 2019; 53: 1801889
- Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the american heart association.Circulation. 2016; 134: e653-e699
- Exercise testing in pulmonary arterial hypertension and in chronic heart failure.Eur Respir J. 2004; 23: 747-751
- Dyspnea: physiological and pathophysiological mechanisms.Annu Rev Med. 1988; 39: 503-515
- Ventilatory efficiency in pulmonary vascular diseases.Eur Respir Rev. 2021; 30https://doi.org/10.1183/16000617.0214-2020
- Ventilatory response to exercise in cardiopulmonary disease: the role of chemosensitivity and dead space.Eur Respir J. 2018; 51https://doi.org/10.1183/13993003.00860-2017
- Prognostic ability of VE/VCO2 slope calculations using different exercise test time intervals in subjects with heart failure.Eur J Cardiovasc Prev Rehabil. 2003; 10: 463-468
- Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension.BMC Pulm Med. 2012; 12: 23
- Diagnosis of pulmonary vascular limit to exercise by cardiopulmonary exercise testing.J Heart Lung Transplant. 2004; 23: 88-95
- Pulmonary gas exchange and exercise performance in pulmonary hypertension.CHEST. 1985; 88: 255S-257S
- Dead space: the physiology of wasted ventilation.Eur Respir J. 2015; 45: 1704-1716
- Mixed-expired and end-tidal CO 2 distinguish between ventilation and perfusion defects during exercise testing in patients with lung and heart diseases.Chest. 2007; 132: 977-983
- Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension.Eur Respir J. 2007; 29: 944-950
- Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertension.Chest. 2007; 131: 1831-1837
- Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial.Eur Heart J. 2017; 38: 1159-1168
- Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise.J Am Coll Cardiol. 1996; 28: 1567-1572
- Usefulness of decrease in oxygen uptake efficiency to identify gas exchange abnormality in patients with idiopathic pulmonary arterial hypertension.PLoS One. 2014; 9: e98889
- Exercise oxygen uptake efficiency slope independently predicts poor outcome in pulmonary arterial hypertension.Eur Respir J. 2014; 43: 1510-1512
- The value of cardiopulmonary exercise testing in the diagnosis of pulmonary hypertension.J Thorac Dis. 2021; 13: 178-188
- Characteristics of cardiopulmonary exercise testing of patients with borderline mean pulmonary artery pressure.Clin Respir J. 2019; 13: 148-158
- Evaluation of end-tidal CO2 pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension.Heart Vessels. 2017; 32: 1350-1357
- Cardiopulmonary exercise testing is an accurate tool for the diagnosis of pulmonary arterial hypertension in scleroderma related diseases.Pharmaceuticals. 2021; 14: 342
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).Eur Heart J. 2016; 37: 67-119
- Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.Rheumatology. 2020; 59: 1581-1586
- Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities.Arthritis Rheum. 2010; 62: 3741-3750
- Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis.Eur Respir J. 2016; 48: 1658-1667
- Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography.RES. 2014; 87: 379-387
- Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society.Eur Heart J. 2022; 43: 183-189
- Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.Eur Respir J. 2020; 55https://doi.org/10.1183/13993003.00189-2020
- Cardiopulmonary exercise testing and pulmonary function testing for predicting the severity of CTEPH.BMC Pulm Med. 2021; 21: 324
- Diagnosis of pulmonary hypertension.Eur Respir J. 2019; 53: 1801904
- Sitaxsentan therapy for pulmonary arterial hypertension.Am J Respir Crit Care Med. 2004; 169: 441-447
- End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives.J Am Coll Cardiol. 2004; 43: S48-S55
- Goal-oriented sequential combination therapy evaluated using cardiopulmonary exercise parameters for the treatment of newly diagnosed pulmonary arterial hypertension - goal-oriented therapy evaluated by cardiopulmonary exercise testing for pulmonary arterial hypertension (GOOD EYE).Circ Rep. 2019; 1: 303-311
- Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy.ERJ Open Res. 2021; 7: 00725-02020
- Effects of exercise training on exercise capacity in pulmonary arterial hypertension: a systematic review of clinical trials.Heart Lung Circ. 2016; 25: 333-341
- Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial.Eur Heart J. 2016; 37: 35-44
- Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients.Eur Respir J. 2012; 39: 119-124
- Exercise hyperventilation and pulmonary gas exchange in chronic thromboembolic pulmonary hypertension: Effects of balloon pulmonary angioplasty.J Heart Lung Transplant. 2022; 41: 70-79
- Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty – A randomized controlled study.IJC Heart & Vasculature. 2020; 29: 100579
- Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.Respir Res. 2019; 20: 250
- Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.Eur Respir J. 2016; 47: 429-460
- Assessment of survival in patients with primary pulmonary hypertension.Circulation. 2002; 106: 319-324
- Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension.Pulm Circ. 2022; 12: e12044
- End-tidal carbon dioxide as a prognostic feature in pulmonary arterial hypertension.Ann ATS. 2017; 14: 896-902
- Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension.J Heart Lung Transpl. 2022; (S1053-2498(22)01844-01847)https://doi.org/10.1016/j.healun.2022.02.021
- The safety of cardiopulmonary exercise testing in a population with high-risk cardiovascular diseases.Circulation. 2012; 126: 2465-2472
- Prognostication in pulmonary arterial hypertension with submaximal exercise testing.Diseases. 2015; 3: 15-23
- Clinical utility of ventilatory and gas exchange evaluation during low-intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension.Respirology. 2021; 26: 264-272
- The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension.Eur Respir Rev. 2013; 22: 487-494
- Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension.Int J Cardiol. 2013; 167: 1193-1198
- Comprehensive exercise capacity and quality of life assessments predict mortality in patients with pulmonary arterial hypertension.Acta Cardiol Sin. 2019; 35: 55-64
- Oxygen uptake efficiency slope predicts poor outcome in patients with idiopathic pulmonary arterial hypertension.J Am Heart Assoc. 2017; 6: e005037
- Successful epoprostenol withdrawal and termination with an aid of the exercise stress test in pulmonary arterial hypertension.Int J Cardiol. 2022; 346: 80-85
- Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension.Am J Physiology-Heart Circulatory Physiol. 2018; 315: H950-H957
- Impaired right ventricular lusitropy is associated with ventilatory inefficiency in pulmonary arterial hypertension.Eur Respir J. 2019; 54https://doi.org/10.1183/13993003.00342-2019
- Dynamic right ventricular–pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension.Pulm Circ. 2019; 9 (2045894019862435)
- Dynamic right ventricular function response to incremental exercise in pulmonary hypertension.Pulm Circ. 2020; 10 (2045894020950187)
- Gas exchange and ventilatory efficiency during exercise in pulmonary vascular diseases.Archivos de Bronconeumología. 2020; 56: 578-585
- Exercise pulmonary hypertension predicts clinical outcomes in patients with dyspnea on effort.J Am Coll Cardiol. 2020; 75: 17-26
- Pulmonary artery hypertension-specific therapy improves exercise tolerance and outcomes in exercise-induced pulmonary hypertension.JACC: Cardiovasc Imaging. 2019; 12: 2576-2579
- Chronic thromboembolic disease: epidemiology, assessment with invasive cardiopulmonary exercise testing, and options for management.Struct Heart. 2021; 5: 120-127
- Pulmonary arterial hypertension-related myopathy: An overview of current data and future perspectives.Nutr Metab Cardiovasc Dis. 2015; 25: 131-139
- Effects of exercise training in patients with idiopathic pulmonary arterial hypertension.Eur Respir J. 2009; 34: 669-675
- Heart rate recovery at 1 min after exercise is a marker of disease severity and prognosis in chronic thromboembolic pulmonary hypertension.RES. 2022; 101: 455-464
- Heart rate recovery is an important predictor of outcomes in patients with connective tissue disease–associated pulmonary hypertension.Pulm Circ. 2015; 5: 565-576
- Heart rate monitoring improves clinical assessment during 6-min walk.Pulm Circ. 2020; 10 (2045894020972572)
- The role of cardiopulmonary exercise testing and training in patients with pulmonary hypertension: making the case for this assessment and intervention to be considered a standard of care.Expert Rev Respir Med. 2020; 14: 317-327
- Daily step counts are associated with hospitalization risk in pulmonary arterial hypertension.Am J Respir Crit Care Med. 2021; 204: 1338-1340
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
